Di Yu
Researcher at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research group Magnus Essand
- Mobile phone:
- +46 70 720 41 96
- E-mail:
- di.yu@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA
Short presentation
Post Doc at Dept. Immunolgy, Genetics and Pathology
My research is focused on viruses-/T cell- based cancer therapy. Group leader: Magnus Essand

Publications
Selection of publications
Part of PLOS ONE, 2013
- DOI for Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures
- Download full text (pdf) of Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures
Part of Journal of Virology, p. 13114-13123, 2011
- DOI for Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors
- Download full text (pdf) of Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors
Recent publications
Part of Upsala Journal of Medical Sciences, 2025
- DOI for Evaluation of drug delivery vehicles for improved transduction of oncolytic adenoviruses in solid tumor tissue
- Download full text (pdf) of Evaluation of drug delivery vehicles for improved transduction of oncolytic adenoviruses in solid tumor tissue
VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
Part of Nature Communications, 2024
- DOI for VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
- Download full text (pdf) of VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
Part of Molecular Therapy Nucleic Acids, 2024
- DOI for Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response
- Download full text (pdf) of Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response
Enhanced Cellular Uptake through Nanotopography-Induced Macropinocytosis
Part of Advanced Functional Materials, 2024
- DOI for Enhanced Cellular Uptake through Nanotopography-Induced Macropinocytosis
- Download full text (pdf) of Enhanced Cellular Uptake through Nanotopography-Induced Macropinocytosis
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
Part of Cancer Cell, p. 1134-1151, 2023
- DOI for Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
- Download full text (pdf) of Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
All publications
Articles in journal
Part of Upsala Journal of Medical Sciences, 2025
- DOI for Evaluation of drug delivery vehicles for improved transduction of oncolytic adenoviruses in solid tumor tissue
- Download full text (pdf) of Evaluation of drug delivery vehicles for improved transduction of oncolytic adenoviruses in solid tumor tissue
VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
Part of Nature Communications, 2024
- DOI for VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
- Download full text (pdf) of VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
Part of Molecular Therapy Nucleic Acids, 2024
- DOI for Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response
- Download full text (pdf) of Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response
Enhanced Cellular Uptake through Nanotopography-Induced Macropinocytosis
Part of Advanced Functional Materials, 2024
- DOI for Enhanced Cellular Uptake through Nanotopography-Induced Macropinocytosis
- Download full text (pdf) of Enhanced Cellular Uptake through Nanotopography-Induced Macropinocytosis
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
Part of Cancer Cell, p. 1134-1151, 2023
- DOI for Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
- Download full text (pdf) of Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
Part of Frontiers in Immunology, 2023
- DOI for Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment
- Download full text (pdf) of Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment
CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours
Part of Nature, p. 1033-1040, 2023
- DOI for CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours
- Download full text (pdf) of CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours
Complementarity-determining region clustering may cause CAR-T cell dysfunction
Part of Nature Communications, 2023
- DOI for Complementarity-determining region clustering may cause CAR-T cell dysfunction
- Download full text (pdf) of Complementarity-determining region clustering may cause CAR-T cell dysfunction
A qPCR-Based Method for Quantification of RCA Contaminants in Oncolytic Adenovirus Products
Part of Frontiers in Molecular Biosciences, 2022
- DOI for A qPCR-Based Method for Quantification of RCA Contaminants in Oncolytic Adenovirus Products
- Download full text (pdf) of A qPCR-Based Method for Quantification of RCA Contaminants in Oncolytic Adenovirus Products
Part of Oncoimmunology, 2022
- DOI for Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-turnor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response
- Download full text (pdf) of Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-turnor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response
Part of Acta Pharmacologica Sinica, p. 977-991, 2022
Part of Nature Biomedical Engineering, p. 830-841, 2022
- DOI for CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers
- Download full text (pdf) of CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers
Part of MOLECULAR THERAPY-ONCOLYTICS, p. 356-366, 2021
- DOI for Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus
- Download full text (pdf) of Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus
Part of MOLECULAR THERAPY-ONCOLYTICS, p. 37-46, 2021
- DOI for IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma
- Download full text (pdf) of IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma
Separable Microneedle Patch to Protect and Deliver DNA Nanovaccines Against COVID-19
Part of ACS Nano, p. 14347-14359, 2021
Part of Nano Letters, p. 2224-2231, 2021
Part of Cell Death and Disease, 2020
- DOI for Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
- Download full text (pdf) of Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
Antischistosomal Properties of Hederacolchiside A1 Isolated from Pulsatilla chinensis
Part of Molecules, 2018
- DOI for Antischistosomal Properties of Hederacolchiside A1 Isolated from Pulsatilla chinensis
- Download full text (pdf) of Antischistosomal Properties of Hederacolchiside A1 Isolated from Pulsatilla chinensis
CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis
Part of Journal of Clinical Investigation, p. 3280-3297, 2018
- DOI for CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis
- Download full text (pdf) of CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis
Part of Oncoimmunology, 2018
Part of Oncoimmunology, 2018
- DOI for Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models
- Download full text (pdf) of Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models
Part of Experimental dermatology, 2018
Multiple nuclear-replicating viruses require the stress-induced protein ZC3H11A for efficient growth
Part of Proceedings of the National Academy of Sciences of the United States of America, 2018
Part of Clinical Cancer Research, p. 1519-1530, 2017
Part of Neuroendocrinology, p. 54-66, 2017
Part of Molecular Cancer Therapeutics, p. 1705-1716, 2017
Part of Scandinavian Journal of Immunology, p. 341-341, 2017
Part of MOLECULAR THERAPY-ONCOLYTICS, p. 67-75, 2017
- DOI for Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity
- Download full text (pdf) of Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity
Part of Molecular Therapy, p. 288-288, 2017
Part of Virology, p. 44-50, 2016
Part of PLOS ONE, 2016
- DOI for A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients
- Download full text (pdf) of A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients
Prospects to improve chimeric antigen receptor T-cell therapy for solid tumors
Part of Immunotherapy, p. 1355-1361, 2016
Part of CANCER IMMUNOLOGY RESEARCH, 2016
Long-term episomal gene transfer for safe engineering of T cells for adoptive cell therapy of cancer
Part of CANCER IMMUNOLOGY RESEARCH, 2016
Part of EMBO Molecular Medicine, p. 702-711, 2016
- DOI for Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer
- Download full text (pdf) of Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer
Part of Science Signaling, 2015
Part of Advanced Functional Materials, p. 3907-3915, 2015
Long-term episomal gene transfer for safe engineering of T-cells for adoptive cell therapy of cancer
Part of Human Gene Therapy, 2014
Part of Journal of immunotherapy (1997), p. 155-162, 2014
Part of Molecular Therapy, 2014
Part of Journal of Immunology, p. 2287-2296, 2014
Part of Molecular Therapy Methods & Clinical Development, 2014
Part of Molecular Therapy, 2014
Part of Molecular Therapy, p. 2008-2018, 2013
- DOI for An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors
- Download full text (pdf) of An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors
Part of PLOS ONE, 2013
- DOI for Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures
- Download full text (pdf) of Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures
Part of Human Gene Therapy, p. 766-775, 2013
- DOI for Tat‐PTD‐modified Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy
- Download full text (pdf) of Tat‐PTD‐modified Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy
Part of Gene Therapy, p. 1052-1062, 2011
Part of Journal of Virology, p. 13114-13123, 2011
- DOI for Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors
- Download full text (pdf) of Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors
Comprehensive doctoral thesis
Manuscripts (preprints)
Multiple viruses rely on the stress-induced protein ZC3H11A for efficient replication
2017
Armed CAR-T cells directed against IL13Rα2 show potent activity against glioblastoma
Preclinical evaluation of CAR20(NAP)-T cells for B cell lymphoma
Complementary-determining region clustering causes CAR-T cell dysfunction